Systemic Chemotherapy with Combination of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor in Unresectable Hepatocellular Carcinoma

被引：0
|
作者：
Chon, Hye Yeon [1 ,2 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Yongin Severance Hosp, Dept Internal Med, 363 Dongbaekjukjeon Daero, Yongin 16995, South Korea
来源：
KOREAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 83卷 / 02期
关键词：
ATEZOLIZUMAB;
D O I：
10.4166/kjg.2024.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：78 / 80
页数：3
相关论文
共 50 条
  • [1] Immune checkpoint inhibitor plus tyrosine kinase inhibitor for unresectable hepatocellular carcinoma in the real world
    Xie, Diyang
    Sun, Qiman
    Wang, Xiaoying
    Zhou, Jian
    Fan, Jia
    Ren, Zhenggang
    Gao, Qiang
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [2] Immune checkpoint inhibitor plus tyrosine kinase inhibitor with or without transarterial chemoembolization for unresectable hepatocellular carcinoma
    Pan, Hongyu
    Ruan, Minghao
    Jin, Riming
    Zhang, Jin
    Li, Yao
    Wu, Dong
    Sun, Wen
    Wang, Ruoyu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Role of Transarterial Chemoembolization in the Era of Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Combination Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Propensity Score Matched Analysis
    Zhang, Jin-Xing
    Hua, Hong-jin
    Cheng, Yuan
    Liu, Sheng
    Shi, Hai-Bin
    Zu, Qing-Quan
    ACADEMIC RADIOLOGY, 2024, 31 (04) : 1304 - 1311
  • [4] Sequential therapy versus first-line tyrosine kinase inhibitor plus immune checkpoint inhibitor therapy for unresectable hepatocellular carcinoma
    Ruan, Minghao
    Yang, Cheng
    Zhao, Jing
    Zhi, Kangkang
    Feng, Xiaochen
    Zhang, Jin
    Jin, Riming
    Li, Yao
    Wu, Dong
    Liu, Hui
    Sun, Wen
    Wang, Ruoyu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Small cell carcinoma of the kidney treated with immune checkpoint inhibitor/tyrosine kinase inhibitor
    Harada, Mirii
    Tomisaki, Ikko
    Shimajiri, Shohei
    Kuretake, Keisuke
    Harada, Kenichi
    Fujimoto, Naohiro
    IJU CASE REPORTS, 2023, 6 (06) : 386 - 389
  • [6] Safety and Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Single Center Experience
    Pan, Xian
    Wu, Shao-Jie
    Tang, Yi
    Zhou, Yan-Feng
    Luo, Jie-Wei
    Fang, Zhu-Ting
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 883 - 892
  • [7] Radioembolization plus Immune Checkpoint Inhibitor Therapy Compared with Radioembolization plus Tyrosine Kinase Inhibitor Therapy for the Treatment of Hepatocellular Carcinoma
    Garcia-Reyes, Kirema
    Gottlieb, Ricki A.
    Menon, Kartikeya M.
    Bishay, Vivian
    Patel, Rahul
    Patel, Rajesh
    Nowakowski, Scott
    Sung, Max W.
    Marron, Thomas U.
    Gansa, William H.
    Zhang, Jack
    Raja, Sahitya C.
    Shilo, Daniel
    Fischman, Aaron
    Lookstein, Robert
    Kim, Edward
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2024, 35 (05) : 722 - 730.e1
  • [8] Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Unresectable Hepatocellular Carcinoma: Efficacy and Systemic Immune Response
    Yang, Fei
    Xu, Gui-Li
    Huang, Jin-Tao
    Yin, Yu
    Xiang, Wei
    Zhong, Bin-Yan
    Li, Wan-Ci
    Shen, Jian
    Zhang, Shuai
    Yang, Jun
    Sun, Hong Peng
    Wang, Wan-Sheng
    Zhu, Xiao-Li
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] VIRAL ETIOLOGY DETERMINES OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR-BASED COMBINATION THERAPY FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA
    Wu, Chi-Jung
    Lee, Pei-Chang
    Hung, Ya-Wen
    Lee, Chieh-Ju
    Chi, Chen-Ta
    Lee, I-Cheng
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    HEPATOLOGY, 2022, 76 : S1376 - S1376
  • [10] Adjuvant therapy in renal cell carcinoma: Tyrosine kinase inhibitor versus immune checkpoint inhibitor
    Zhou, Qingbo
    Liu, Jianjiang
    Xie, Shaoqin
    MEDICINE, 2024, 103 (22) : E38329
12345